Elizabeth Holmes

Elizabeth Holmes
Born	(1984-02-03) February 3, 1984 Washington, D.C., U.S.
Occupation	Entrepreneur
Known for	Founder and former CEO of Theranos

Elizabeth Anne Holmes (born February 3, 1984) is an American entrepreneur in the biotechnology sector who was convicted of fraud connected to her company, Theranos. The firm gained a high valuation by asserting it had transformed blood testing through techniques that required only minimal blood quantities, such as those obtained via a fingerprick. In 2015, Forbes recognized Holmes as the youngest and richest self-made female billionaire in the United States, based on Theranos’s estimated worth of $9 billion. Nevertheless, following fraud allegations that surfaced in 2016, Forbes removed her net worth entirely, and Fortune included her among "The World's 19 Most Disappointing Leaders."

Theranos’s downfall began in 2015 amid investigative journalism and regulatory inquiries that challenged the reliability of its technology and Holmes’s honesty with investors and regulators. In 2018, the U.S. Securities and Exchange Commission charged Theranos, Holmes, and former COO Ramesh "Sunny" Balwani with raising $700 million by making deceptive claims about their blood-testing devices. Holmes resolved the charges by paying a $500,000 penalty, surrendering 18.9 million shares, giving up voting control, and agreeing to a decade-long prohibition from holding officer or director roles in publicly traded companies.

Throughout much of Theranos’s existence, Holmes was involved in a concealed romantic relationship with Balwani. Together, they oversaw a company culture characterized by secrecy and intimidation; employees who voiced concerns were frequently sidelined or terminated. After Theranos collapsed, Holmes married hotel heir William "Billy" Evans in 2019; the couple has two children born in 2021 and 2023.

In June 2018, a federal grand jury indicted both Holmes and Balwani on charges of fraud. In January 2022, Holmes was found guilty of defrauding investors but was acquitted of charges related to defrauding patients. She received a prison sentence to be served at Federal Prison Camp, Bryan, commencing May 30, 2023, along with an order to pay $452 million in restitution. The initial legitimacy of Theranos was partly attributed to Holmes’s connections with prominent figures such as Henry Kissinger, George Shultz, James Mattis, and Betsy DeVos—individuals with extensive experience in U.S. government.

Early life

Elizabeth Anne Holmes entered the world on February 3, 1984, in Washington, D.C.. Her father, Christian Rasmus Holmes IV, held a vice presidential position at Enron before occupying executive roles within government agencies including USAID, the EPA, and USTDA. Her mother, Noel Anne (née Daoust), served as staff for a Congressional committee. Holmes has Danish ancestry; one of her paternal forebears, Charles Louis Fleischmann, was the founder of Fleischmann's Yeast, a family noted for its entrepreneurial accomplishments.

Holmes completed her education at St. John's School in Houston where she demonstrated early business acumen by reportedly selling C++ compilers to universities in China. She also pursued Mandarin lessons and participated in Stanford University’s summer program for Mandarin studies. In 2002, she enrolled at Stanford University majoring in chemical engineering, engaging as a research assistant and laboratory worker within the School of Engineering. She was affiliated with Kappa Alpha Theta.

Following her freshman year, Holmes gained experience at the Genome Institute of Singapore, conducting blood tests related to SARS-CoV-1. In 2003, she submitted her first patent application for a wearable device designed to deliver medication. Holmes has disclosed that she was sexually assaulted while at Stanford in 2003. She left Stanford’s School of Engineering in March 2004 and used her tuition funds as initial capital to start a consumer health technology enterprise.

Establishment

Holmes launched Real-Time Cures in Palo Alto, California in 2003 with the mission to "make healthcare accessible to all." Driven by a personal aversion to needles, her goal was to conduct blood testing using minimal blood samples. Although medical professionals doubted the feasibility of her assertions, Holmes gained backing from her mentor and engineering dean, Channing Robertson. She later rebranded the enterprise as Theranos, combining "therapy" and "diagnosis," after deciding the original name invited too much skepticism. Robertson became the inaugural board member and facilitated connections with venture capital investors.

Capital acquisition and growth

By December 2004, Holmes had secured $6 million in funding for Theranos. By the close of 2010, venture capital investments exceeded $92 million. In July 2011, Holmes encountered former Secretary of State George Shultz, who soon joined Theranos' board. Over the following three years, Holmes assembled what was described as "the most prestigious board in U.S. corporate history."

Theranos remained in "stealth mode" without public announcements or an online presence until September 2013, when it revealed a collaboration with Walgreens to open blood sample collection sites inside stores. Holmes was interviewed by Medscape's editor-in-chief Eric Topol, who commended her for "this remarkable reinvention of laboratory medicine." Media exposure intensified in 2014, with Holmes featured on the covers of Fortune, Forbes, T: The New York Times Style Magazine, and Inc..

In 2014, Forbes recognized Holmes as the youngest self-made female billionaire worldwide and ranked her #110 on the Forbes 400. Theranos reached a valuation of $9 billion and had attracted over $400 million in venture funding. By year-end 2014, Holmes held 18 patents registered in the U.S. along with 66 international patents. In 2015, she secured partnerships with Cleveland Clinic, Capital Blue Cross, and AmeriHealth Caritas to implement Theranos technology.

Collapse

John Carreyrou of The Wall Street Journal initiated an undercover investigation into Theranos after receiving a tip from a medical professional questioning the Edison blood testing device’s accuracy. He conducted interviews with whistleblowers and acquired confidential company documents. Upon becoming aware of the inquiry, Holmes hired attorney David Boies to intimidate both the newspaper and whistleblowers through legal threats and financial pressure.

Despite these tactics, in October 2015, the Journal published Carreyrou’s exposé revealing that the Edison device yielded unreliable results and that Theranos depended largely on standard commercial machines for its testing. Carreyrou continued his reporting on Theranos’ problems and Holmes's behavior, culminating in his 2018 book Bad Blood: Secrets and Lies in a Silicon Valley Startup.

Holmes refuted all accusations, dismissing the Journal as tabloid journalism and pledging to release data to support their testing claims. She appeared on CNBC's Mad Money, asserting that Theranos would revolutionize healthcare despite ongoing criticism.

In January 2016, after inspecting Theranos’s Newark laboratory, the Centers for Medicare and Medicaid Services (CMS) issued a warning citing staff competency issues and equipment irregularities. By March, CMS proposed a two-year prohibition barring Holmes from owning or managing certified clinical laboratories due to unresolved compliance problems. Holmes publicly expressed deep disappointment and committed to overhauling the lab with new advisory guidance.

In July 2016, CMS officially imposed a two-year ban on Holmes from operating blood-testing services; Theranos filed an appeal. Shortly thereafter, Walgreens ended its partnership and shut down Theranos testing centers. The FDA mandated halting use of the Capillary Tube Nanotainer device—one of Theranos’s key inventions.

Arizona filed suit against Theranos in 2017 for marketing 1.5 million blood tests while withholding crucial information; the company settled for $4.65 million including reimbursements and penalties. Additional probes by the FBI and class action lawsuits ensued, with Holmes denying any misconduct.

On May 16, 2017, nearly 99% of shareholders consented to drop litigation in exchange for preferred stock; Holmes released some equity shares to prevent dilution among shareholders who did not participate.

In March 2018, the SEC charged Holmes and former president Ramesh Balwani with fraud for raising more than $700 million by promoting false claims such as Department of Defense usage. The company falsely reported $100 million revenue for 2014 instead of approximately $100,000. Holmes resolved charges by relinquishing voting control, returning shares, accepting a decade-long ban from public company leadership roles, and paying a $500,000 penalty.

At its height in 2015, Theranos employed over 800 staff but reduced headcount significantly during late 2016 and early 2017 layoffs. By April 2018, plans were announced to shrink personnel below two dozen; most remaining employees were dismissed by August. On September 5, 2018, Theranos commenced formal dissolution proceedings and allocated remaining assets to creditors.

U.S. v. Holmes, et al.

Following a comprehensive two-year probe by the U.S. Attorney's Office for the Northern District of California, a federal grand jury indicted Elizabeth Holmes and Ramesh Balwani on June 15, 2018. The charges included nine counts of wire fraud and two counts of conspiracy to commit wire fraud. Both defendants entered pleas of not guilty. Prosecutors accused them of orchestrating two fraudulent schemes: one targeting investors and the other involving doctors and patients. Holmes stepped down as Theranos CEO but retained her role as chairwoman.

The trial commenced on August 31, 2021, in the Northern District of California under Judge Edward Davila's supervision. Its start was postponed due to the COVID-19 crisis and Holmes’s pregnancy. During seven days on the witness stand, Holmes asserted that she had been deceived by employees and dominated by Balwani amid their ongoing romantic involvement. The evidence presented revealed her participation in staged demonstrations, fabricated reports, deceptive contract assertions, and inflated financial statements.

On January 3, 2022, the jury convicted Holmes on four charges related to defrauding investors—three wire fraud counts plus one conspiracy count—while acquitting her on four counts concerning patient fraud. Additionally, a mistrial was declared on three other investor-related counts, which were subsequently dismissed. Holmes remained free on $500,000 bail secured by property and faced potential sentences of up to 20 years imprisonment per count, along with fines and restitution.

Judge Davila sentenced Holmes on November 18, 2022, to eleven years and three months in federal prison and ordered restitution totaling $452 million payable by both Holmes and Balwani to victims of the fraud. The judge recommended her placement at Federal Prison Camp Bryan in Texas. After making childcare arrangements for her two children, Holmes reported to prison on May 30, 2023. The Federal Bureau of Prisons estimated her release date as 2032, approximately two years earlier than the full term due to good behavior.

Holmes appealed her conviction and sentence to the Ninth Circuit Court of Appeals, citing alleged legal errors including the admission of government reports and restrictions on cross-examination. In June 2024, a panel consisting of Judges Jacqueline Nguyen, Ryan D. Nelson, and Mary M. Schroeder heard oral arguments. By February 2025, the Ninth Circuit upheld both her conviction and sentence.

Promotional activities

In June 2015, Holmes collaborated with Carlos Slim to broaden access to blood testing services within Mexico. Later that year in October, she initiated the #IronSisters campaign aimed at encouraging women to pursue careers in science, technology, engineering, and mathematics. During 2015 as well, she influenced legislation in Arizona permitting individuals to directly obtain and pay for laboratory tests without insurance or medical provider authorization while exaggerating the reliability of Theranos’s technology.

Connections

Theranos’s board members and investors included several notable personalities. Holmes’s earliest major backer was Silicon Valley venture capitalist Tim Draper, who contributed $1 million following her initial pitch. The investor group eventually encompassed Rupert Murdoch, members of the Walton family, the DeVos family (including Betsy DeVos), the Cox family associated with Cox Enterprises, and Carlos Slim Helú, all of whom incurred substantial financial losses after Theranos’s downfall.

George Shultz was among Holmes’s first board appointees and played a key role in attracting other distinguished members. The board comprised twelve individuals including former U.S. secretaries Henry Kissinger and William J. Perry, future defense secretary James Mattis, retired Admiral Gary Roughead, ex-senators Bill Frist and Sam Nunn, as well as former CEOs Dick Kovacevich (Wells Fargo) and Riley Bechtel (Bechtel).

Recognition and public image

Prior to the downfall of Theranos, Holmes was widely celebrated. In 2015, she secured a position on the Harvard Medical School Board of Fellows and was included in Time magazine's list of the "Time 100 most influential people". That same year, she received the Under 30 Doers Award from Forbes and was ranked 73rd among "the world's most powerful women" by the publication. Additionally, Holmes was honored as Woman of the Year by Glamour and awarded an Honorary Doctor of Humane Letters from Pepperdine University.

Holmes became the youngest recipient of the 2015 Horatio Alger Award and had previously been featured in Fortune's Businessperson of the Year and 40 Under 40 lists. She was also named one of Bloomberg's 50 Most Influential individuals in 2015. During that year, actor Jared Leto presented her with a Glamour Award, while then-President Barack Obama appointed her as a Presidential Ambassador for Global Entrepreneurship. Nevertheless, by 2016, Fortune included her among "The World's 19 Most Disappointing Leaders".

Holmes openly admired Apple founder Steve Jobs, often mimicking his signature style by wearing a black turtleneck sweater. She claimed to have adopted this attire since founding Theranos in 2003, although some accounts suggest this style emerged later. An employee mentioned that in 2007, she was advised to emulate Jobs’s iconic Issey Miyake turtleneck.

Her public speaking featured a notably deep baritone voice, which some former colleagues believed to be an affectation; however, others, including her family, insisted it was genuine. In a 2023 interview with The New York Times, Holmes admitted that the deep voice was deliberately affected and spoke in her natural higher pitch.

Personal life

Holmes had a romantic relationship with Ramesh "Sunny" Balwani, a technology entrepreneur born in Pakistan who immigrated first to India and then to the United States. They met in 2002 during a Stanford Mandarin program when Holmes was 18 years old; Balwani was nineteen years her senior and married at that time. After divorcing in 2002, Balwani began dating Holmes in 2003, coinciding with her departure from university. The couple cohabited beginning in 2005. Although Balwani officially joined Theranos as COO in 2009, he had been advising Holmes from the company's inception. He left Theranos amid investigations in 2016; Holmes contends she dismissed him, while Balwani claims his departure was voluntary.

In November 2021, Holmes testified about having been sexually assaulted while at Stanford and described seeking solace from Balwani, whom she characterized as controlling and abusive throughout their decade-long relationship. She denied allegations that Balwani coerced her into making false statements to investors and partners. Balwani has categorically denied all abuse claims.

Before settling legal matters in March 2018, Holmes owned half of Theranos's shares. In 2015, Forbes ranked her among the wealthiest self-made women in the U.S., estimating her net worth at $4.5 billion. By June 2016, Theranos’s valuation had plummeted to $800 million, effectively rendering her holdings nearly worthless due to other investors’ preferred shares. Reports indicate Holmes owed $25 million to Theranos related to stock options but did not receive cash or sell any shares.

Holmes met William "Billy" Evans early in 2017 and became engaged to the hotel heir by early 2019. They reportedly married privately around mid-2019, though Evans is often referred to as her partner. Holmes gave birth to a son in July 2021 and a second child in late 2022 shortly before sentencing. Court documents implied the second pregnancy might have been intended to delay imprisonment; Holmes refuted this claim, stating the child was conceived prior to indictment. Before incarceration, she resided with Evans at the Mortimer Fleishhacker House estate located in Woodside, California.

In January 2022, NPR obtained a partial police report from October 2003 documenting Holmes’s allegation of sexual assault at a Stanford fraternity house. This report corroborated her trial testimony regarding how that incident influenced her decision to establish Theranos later that year.

In the media

The case surrounding Holmes has cast a shadow over female entrepreneurs within science and healthcare sectors, who frequently face unfavorable comparisons to her. Technology journalist Erin Griffith observed in The New York Times that Holmes "continues to loom large across the start-up world" due to the boldness of her narrative; such comparisons have been described as "pernicious." Holmes’s story has been depicted across numerous media platforms:

• In June 2016, Deadline Hollywood announced that Jennifer Lawrence would portray Holmes in a film directed by Adam McKay based on John Carreyrou's then-unpublished book Bad Blood: Secrets and Lies in a Silicon Valley Startup. By December 2021, Apple Studios and Legendary Pictures were slated to produce and distribute this project. However, Lawrence withdrew from the role in November 2022 following Amanda Seyfried’s acclaimed Emmy-winning portrayal in The Dropout, stating "we don't need to redo that."

• John Carreyrou released his book Bad Blood in May 2018, providing an extensive account of Holmes’s life and Theranos’s internal operations. Film rights were acquired by Legendary Entertainment nearly two years prior to its publication.

• January 2019 saw ABC News and Nightline launch The Dropout, featuring interviews and deposition recordings with key figures such as Holmes, Balwani, whistleblower Tyler Shultz, and board members; it also included an interview with Balwani’s legal counsel.

• HBO debuted the documentary The Inventor: Out for Blood in Silicon Valley in March 2019, chronicling Holmes’s assertions alongside Theranos’s collapse; it concludes with indictments against Holmes and Balwani for multiple offenses.

• In June 2021, the US comedy-drama series Younger incorporated a musical number about notorious scammers featuring Elizabeth Stanley portraying Holmes.

• On August 8, 2021, Australia's program 60 Minutes aired coverage on Theranos’s saga and Holmes's forthcoming trial.

• Hulu premiered the miniseries The Dropout in March 2022 based on the podcast; Amanda Seyfried starred as Holmes, earning both Primetime Emmy and Golden Globe awards for her performance.

• In May 2023, as she prepared for incarceration, Holmes granted her first interview in seven years to The New York Times.

• In a rare prison interview conducted in 2025, Holmes expressed ongoing intentions to transform medical testing practices.

External links

• USPTO compilation of U.S. patents credited to Holmes (120 patents recorded as of January 4, 2022)